{"title":"Gebruik van melanotan I en II door de bevolking; gebruik is niet wettig, niet gereguleerd en mogelijk schadelijk","authors":"P. L. Bruijnzeel","doi":"10.1007/BF03079997","DOIUrl":"https://doi.org/10.1007/BF03079997","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"108-109"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079997","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Kosteneffectiviteit van ‘drug-eluting stents’ in vergelijking met traditionele stents","authors":"P. Toll","doi":"10.1007/BF03079998","DOIUrl":"https://doi.org/10.1007/BF03079998","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"95 1","pages":"109-109"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079998","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Depositie van salbutamol tijdens een acute exacerbatie van astma of COPD na inhalatie van poeder met een voorzetkamer en een vloeistof met een vernevelaar","authors":"P. L. Bruijnzeel","doi":"10.1007/BF03080000","DOIUrl":"https://doi.org/10.1007/BF03080000","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"111-111"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03080000","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preventie van veneuze tromboembolie met dabigatranetexilaat of enoxaparine: een gerandomiseerd, dubbelblind, ‘non-interiority’ onderzoek","authors":"J. Sitsen","doi":"10.1007/BF03079985","DOIUrl":"https://doi.org/10.1007/BF03079985","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"98-99"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079985","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cardiovasculaire toxiciteit van rofecoxib in de APPROVe studie","authors":"H. J. M. G. Nelissen-Vrancken","doi":"10.1007/BF03079989","DOIUrl":"https://doi.org/10.1007/BF03079989","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"102-103"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079989","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Wel en wee van OTC","authors":"G. Laekeman","doi":"10.1007/BF03079999","DOIUrl":"https://doi.org/10.1007/BF03079999","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"109-111"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079999","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gebruik van erytropoëse-stimulerende stoffen verhoogt de mortaliteit bij kankerpatiënten","authors":"P. Toll","doi":"10.1007/BF03079984","DOIUrl":"https://doi.org/10.1007/BF03079984","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"68 1","pages":"98-98"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079984","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Wat is de optimale dosering van aspirine bij de preventie van cardiovasculaire ziekte","authors":"E. V. Does","doi":"10.1007/BF03079992","DOIUrl":"https://doi.org/10.1007/BF03079992","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"104-105"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079992","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mycofenolaatmofetil in de dermatologie","authors":"P. Bruijnzeel","doi":"10.1007/BF03079991","DOIUrl":"https://doi.org/10.1007/BF03079991","url":null,"abstract":"","PeriodicalId":92937,"journal":{"name":"Medisch-farmaceutische mededelingen","volume":"47 1","pages":"103-104"},"PeriodicalIF":0.0,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03079991","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51871662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}